Adeline Chua

About

Highly motivated and results driven professional with more than ten years of diverse experience in biomedical sciences research, communications, and education. 9 years of experience in pharmaceutical industry research, primarily in novel drug discovery for the treatment of infectious diseases and cancer. Expertise in both cell based assay development and validation for high throughput drug screening and cancer biomarker discovery. Proven ability as a creative problem solver with leadership qualities and project management skills. Results-oriented, adaptive and effective team player that thrives on the challenge of finding better therapies for human diseases. Specialties: Infectious diseases, BSL3 certified, Animal work certified, Radioactive work certified, Assay development, Drug screening, Cancer Biology, Biomarker discovery, Systems biology

Experience

• Senior Research Fellow at A*STAR Infectious Diseases Labs - ID Labs
  Apr 2021 - Present · 5 yrs 4 mos

• Senior Research Fellow at Singapore Immunology Network (A*STAR)
  Jan 2019 - Apr 2021 · 2 yrs 4 mos

• PHD Candidate at University of Otago
  Jul 2016 - Dec 2018 · 2 yrs 6 mos

• Novartis (5 yrs 3 mos)
  • Scientist II
    Jan 2014 - Jun 2016 · 2 yrs 6 mos

  • Scientist I
    Apr 2011 - Dec 2013 · 2 yrs 9 mos

    Was primarily involved in lipid profile analysis, assay development and drug screening against drug resistant M.tuberculosis. More recent responsibilities include assay development for blood-stage and liver-stage malaria.

• Associate Scientist at Lilly Singapore Centre for Drug Discovery (Eli Lilly and Co.)
  Jan 2007 - Dec 2010 · 4 yrs

  Primarily involved in cancer biomarker identification and validation using gene targeting technologies.